Skip to content

PHARMONY

Active Private limited companyfounded 2010active for 16 yearsAvenue d'Ecolys 2, 5020 NamurKBO/BCE: BE 0830.310.102 subsidiary of

Lifetime

15 annual accounts with figures on one time axis
peak of €460,000 in 2025
€460,000▲ 21.7%
lowest -€711,183 in 2021
-€255,925▲ €92,805
peak of €26,013 in 2011
-€4.1m▼ €255,925
€4.3m▲ 8.4%
peak of 11.9 FTE in 2022
8.6 FTE▲ 7.5%
Board6 names since 2010
2 directors and 1 other
Owners
  
Documentsfilings and deeds
06-08-20266 days late
2025abbreviated format
Gross margin from €377,931 to €460,000Loss of €255,925Cash from €8,541 to €21,156

Key points

from the 2025 annual accounts

Equity

-€4.1m
202020212022202320242025

Debts exceed assets in financial year 2025.

Losses

-€4.2m in nine years
2017201820192020-711,1832021202220232024-255,9252025

Every financial year from 2017 to 2025 closed with a loss. 2021 was the heaviest.

Debts

€4.3m 1,899% of the balance sheet
Financial debts 62%Suppliers 34%Taxes and wages 3%

Of this, €1.6m falls due within a year.

Staff

8.6 FTE from 11.9 in 2022

Between 2022 and 2025, the number of full-time equivalents fell by 28%.

Filings

15 annual accounts since 2011
AprilJune31 JulyOctober201520202025

Four of the last ten came late. The 2023 accounts came in latest, 29 days after the end of the period.

Position in the sector

-1798.8%

Lower solvency than 95% of companies in head offices and management consultancy. The sector median is 52.0%, over 10,662 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,922 companies had the same profile as PHARMONY has now. Each dot stands for 18 companies, two years later.

85.3%
were still trading
8.3%
stopped another way
5.8%
went bankrupt
  • Micro
  • 10 to 20 years old
  • negative equity
  • a loss of 10% of the balance sheet or more

Another 0.6% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,922 companies, not a prediction for PHARMONY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • consolidatesscore equity €270,514 (2025) · annual accounts 30-09-2014
  • deed of 22-02-2017
Board & ownership

Recent changes

resigns as director General meeting of 13-03-2023 · Gazette deed
resigns as director appointed as director · General meeting of 25-06-2021 · Gazette deed
changes role from manager to director appointed as director · Discharge granted to · General meeting of 14-09-2020 · Gazette deed
Registered office moved from Evere to Namur The registered office moved from Avenue du Frioul, 36 bte 41-B-1140 Evere to Avenue Ecolys, 2-5020 Namur (Suarlée) · resigns as manager · acts as permanent representative · General meeting of 27-12-2018 · Gazette deed
All 29 events

Comparable companies

same main activity, similar in size and age
Company
PHARMONY Namur €226,511 €460,000 -1798.8% 8.6
M&P Survey Bruges €244,092 €569,910 31.3% 7.1
PROGRESS COMMUNICATIONS Antwerp €316,886 €373,421 45.2% 6.4
FLUXOLOGY Sint-Pieters-Leeuw €353,317 €452,107 59.5% 6.9
CIRCL Digital Marketing Ghent €291,760 €626,725 38.5% 6
PAPILIUM Sint-Martens-Latem €389,704 €549,752 38.8% 8
PROgrès-PArticipation-Gestion en Economie Sociale Namur €326,593 €863,970 -106.5% 9.8

These companies have the same main activity as PHARMONY: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €244,000 and €390,000, founded between 2006 and 2010.

Official details

Source: KBO
Status
Active since 15-10-2010Normal situation
Registered office
92 active companies are registered at this addressOf these, 4 started in the 12 months before 20 November 2026. Source: KBO register, as of 20 November 2026.
Activity
Business and other management consultancyNACE 70200and 1 other
Establishment unit
2.193.112.3925020 Namur, registered on 09-11-2010
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2025

≈ €700,000estimated
€226,511▲ 50.9%
Employeeson 31-12-2025
9▲ 12.5%
Filing
Filed on 06-08-2026
Financials

Insights on PHARMONY

PHARMONY files the abbreviated format. That format states no turnover. The gross margin rose from €34,305 in 2011 to €460,000 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMONY

What is the company number of PHARMONY?
The company number of PHARMONY is 0830.310.102. The VAT number is the same number with BE in front: BE 0830.310.102.
Where is PHARMONY based?
The registered office is at Avenue d'Ecolys 2, 5020 Namur.Company details
What does PHARMONY do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of PHARMONY?
PHARMONY is a private limited company (BV).
When was PHARMONY founded?
PHARMONY was founded on 15-10-2010.
Is PHARMONY still active?
Yes, PHARMONY is an active enterprise in the KBO register.
How many employees does PHARMONY have?
PHARMONY had an average of 8.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMONY?
The turnover in financial year 2025 is about €700,000. This figure is estimated from the gross margin of €460,000 and 72 comparable companies (NACE 70200). It probably lies between €540,000 and €1.3m.
Is PHARMONY profitable?
In financial year 2025, PHARMONY made a loss of €255,925.
Where can I find the annual accounts of PHARMONY?
PHARMONY filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMONY due?
PHARMONY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.